Zucomet PG 2mg/500mg/15mg Tablet SR
Marketer
Zuciya Lifesciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Zucomet PG 2mg/500mg/15mg Tablet SR
Diabetic patients may find relief with the extended-release formulation, Zucomet PG 2mg/500mg/15mg Tablet SR, a triple-combination medication designed for glycemic management. This medication, used alongside a balanced diet and regular physical activity, assists adults with type 2 diabetes in achieving better blood glucose control by enhancing insulin effectiveness. Dosage and duration must adhere strictly to your physician's instructions; ingestion with food minimizes gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; never double the dose. Excessive intake risks hypoglycemia (low blood sugar). Concurrent use with other antidiabetic drugs, alcohol, or meal skipping elevates the hypoglycemia risk; diligent blood glucose monitoring is crucial. Potential side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, individuals with pre-existing kidney, liver, or heart conditions, or those who are pregnant or breastfeeding, must consult their doctor. Baseline kidney function assessment will precede treatment initiation. Limit alcohol consumption to mitigate potential adverse reactions.
Primary Ingredients of Zucomet PG 2mg/500mg/15mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Zucomet PG 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Zucomet PG 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Zucomet PG 2mg/500mg/15mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Zucomet PG 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Zucomet PG 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Zucomet PG 2mg/500mg/15mg SR tablets with a meal.
How Zucomet PG 2mg/500mg/15mg Tablet SR works:
Zucomet PG 2mg/500mg/15mg Extended-Release Tablets contain glimepiride, metformin, and pioglitazone—three antidiabetic agents with complementary actions. This triple-drug combination enhances blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin sensitivity. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Zucomet PG 2mg/500mg/15mg SR Tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Zucomet PG 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing this medication. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Zucomet PG tablets (2mg/500mg/15mg) are likely not safe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience such symptoms.
KidneyCAUTION
Patients with kidney impairment should use the extended-release Zucomet PG 2mg/500mg/15mg tablet cautiously, potentially requiring dosage modification. Physician consultation is recommended. The medication is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Zucomet PG 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is recommended. Zucomet PG 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Zucomet PG 2mg/500mg/15mg Tablet SR :
Should you forget to take your Zucomet PG 2mg/500mg/15mg SR Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Zucomet PG 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently